BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30040303)

  • 1. [The accuracy of patients' perceptions of the risks associated with localised prostate cancer treatments].
    van Stam MA; Aaronson NK; van der Poel HG; van der Voort van Zyp JRN; Tillier CN; Horenblas S; Bosch JLHR
    Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The accuracy of patients' perceptions of the risks associated with localised prostate cancer treatments.
    van Stam MA; van der Poel HG; van der Voort van Zyp JRN; Tillier CN; Horenblas S; Aaronson NK; Ruud Bosch JLH
    BJU Int; 2018 Mar; 121(3):405-414. PubMed ID: 28960827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Psychological and Quality-of-life Effects of Active Surveillance and Watchful Waiting After Diagnosis of Low-risk Localised Prostate Cancer.
    Egger SJ; Calopedos RJ; O'Connell DL; Chambers SK; Woo HH; Smith DP
    Eur Urol; 2018 Jun; 73(6):859-867. PubMed ID: 28851582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.
    Johansson E; Steineck G; Holmberg L; Johansson JE; Nyberg T; Ruutu M; Bill-Axelson A;
    Lancet Oncol; 2011 Sep; 12(9):891-9. PubMed ID: 21821474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
    Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
    BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
    Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey.
    Lehto US; Tenhola H; Taari K; Aromaa A
    Br J Cancer; 2017 Mar; 116(7):864-873. PubMed ID: 28222069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.
    Madalinska JB; Essink-Bot ML; de Koning HJ; Kirkels WJ; van der Maas PJ; Schröder FH
    J Clin Oncol; 2001 Mar; 19(6):1619-28. PubMed ID: 11250990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Salvage Radiotherapy and its Timing on the Health-related Quality of Life of Prostate Cancer Patients.
    van Stam MA; Aaronson NK; Pos FJ; Bosch JL; Kieffer JM; Tillier CN; van der Poel HG
    Eur Urol; 2016 Nov; 70(5):751-757. PubMed ID: 27016464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications from treatment for prostate carcinoma among men in the Detroit area.
    Schwartz K; Bunner S; Bearer R; Severson RK
    Cancer; 2002 Jul; 95(1):82-9. PubMed ID: 12115320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological and functional effect of different primary treatments for prostate cancer: A comparative prospective analysis.
    Sciarra A; Gentilucci A; Salciccia S; Von Heland M; Ricciuti GP; Marzio V; Pierella F; Musio D; Tombolini V; Frantellizzi V; Pasquini M; Maraone A; Guandalini A; Maggi M
    Urol Oncol; 2018 Jul; 36(7):340.e7-340.e21. PubMed ID: 29706458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.
    Chou R; Croswell JM; Dana T; Bougatsos C; Blazina I; Fu R; Gleitsmann K; Koenig HC; Lam C; Maltz A; Rugge JB; Lin K
    Ann Intern Med; 2011 Dec; 155(11):762-71. PubMed ID: 21984740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course and predictors of symptoms after primary prostate cancer therapy.
    Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
    J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review.
    Lardas M; Liew M; van den Bergh RC; De Santis M; Bellmunt J; Van den Broeck T; Cornford P; Cumberbatch MG; Fossati N; Gross T; Henry AM; Bolla M; Briers E; Joniau S; Lam TB; Mason MD; Mottet N; van der Poel HG; Rouvière O; Schoots IG; Wiegel T; Willemse PM; Yuan CY; Bourke L
    Eur Urol; 2017 Dec; 72(6):869-885. PubMed ID: 28757301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of repeat prostate biopsies on functional outcomes after radical prostatectomy.
    Rosenbaum CM; Mandel P; Tennstedt P; Preisser F; Marks P; Chun FK; Graefen M; Tilki D; Salomon G
    Urol Oncol; 2018 Mar; 36(3):91.e17-91.e22. PubMed ID: 29246393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer?
    Sun M; Abdollah F; Hansen J; Trinh QD; Bianchi M; Tian Z; Briganti A; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    J Sex Med; 2012 Nov; 9(11):2961-9. PubMed ID: 22672479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual function with localized prostate cancer: active surveillance vs radical therapy.
    van den Bergh RC; Korfage IJ; Roobol MJ; Bangma CH; de Koning HJ; Steyerberg EW; Essink-Bot ML
    BJU Int; 2012 Oct; 110(7):1032-9. PubMed ID: 22260273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European population.
    Becker A; Tennstedt P; Hansen J; Trinh QD; Kluth L; Atassi N; Schlomm T; Salomon G; Haese A; Budaeus L; Michl U; Heinzer H; Huland H; Graefen M; Steuber T
    BJU Int; 2014 Jul; 114(1):38-45. PubMed ID: 24053677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Implantation of a Penile Prosthesis and Adjustable Continence Therapy ProACT in Patients with Erectile Dysfunction and Urinary Incontinence after Radical Prostatectomy: Results of a Prospective Pilot Study.
    Yiou R; Binhas M
    J Sex Med; 2015 Dec; 12(12):2481-4. PubMed ID: 26611356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.